Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q1 2019 · 10-Q
Revenue$216.00K$216.00K+8.5% vs Q1 2018 Net Income-$3.67M-$3.67MN/M vs Q1 2018 EPS Diluted-$0.86-$0.86N/M vs Q1 2018 Operating Income-$3,687,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Free Cash Flowderived-$2,520,000N/M Margins · derivedOperating margin-1706.9%+112.2 pt vs Q1 2018
Net margin-1696.8%+104.2 pt vs Q1 2018
ended Mar 31, 2019 · filed May 15, 2019 · 45 d after period end